2024-02-13 08:25:14 ET
Summary
- Coya Therapeutics has strengthened its strategic positioning with a licensing deal with Dr. Reddy's, providing significant financial derisking and expanding its pipeline.
- The company has proven its ability to execute business development activities and is in a strong position for upcoming clinical success and potential regulatory approval.
- Multiple catalysts such as Alzheimer's topline data or additional business development deals could move shares higher.
...
Read the full article on Seeking Alpha
For further details see:
Coya Therapeutics In Catbird Seat Following Dr. Reddy's Licensing Deal